Incorporation of Pseudouridine Into mRNA Yields Superior Nonimmunogenic Vector With Increased Translational Capacity and Biological Stability
Top Cited Papers
Open Access
- 1 November 2008
- journal article
- Published by Elsevier in Molecular Therapy
- Vol. 16 (11), 1833-1840
- https://doi.org/10.1038/mt.2008.200
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Vaccination with Messenger RNA (mRNA)Published by Springer Nature ,2008
- mRNA-based gene transfer as a tool for gene and cell therapy.2007
- Activation of the protein kinase PKR by short double-stranded RNAs with single-stranded tailsRNA, 2004
- Messenger RNA-based vaccinesExpert Opinion on Biological Therapy, 2004
- Cancer immunotherapy with mRNA‐transfected dendritic cellsImmunological Reviews, 2004
- Species-Specific Recognition of Single-Stranded RNA via Toll-like Receptor 7 and 8Science, 2004
- mRNA Is an Endogenous Ligand for Toll-like Receptor 3Journal of Biological Chemistry, 2004
- An advanced culture method for generating large quantities of highly pure dendritic cells from mouse bone marrowJournal of Immunological Methods, 1999
- The tobacco etch viral 5′ leader and poly(A) tail are functionally synergistic regulators of translationGene, 1995
- Direct Gene Transfer into Mouse Muscle in VivoScience, 1990